Pharmacological modulation of metabotropic glutamate receptor subtype 5 and 7 impairs extinction of social fear in a time-point-dependent manner
Introduction
Several psychiatric disorders, such as posttraumatic stress disorder (PTSD), panic disorder, specific phobias and social anxiety disorder (SAD) involve learned components. Memories triggered by trauma-associated cues induce fear and anxiety and contribute to the development and maintenance of symptoms. Such traumatic memories can also be induced experimentally by repeatedly pairing initially neutral cues (e.g. odors, tones, visual stimuli, social stimuli) with an unconditioned stimulus (e.g. physical punishment or onset of drug effect). Consequently, the neutral cue acquires the ability to elicit conditioned responses, such as fear and anxiety. Therapeutic approaches aimed at reducing the impact of trauma-associated cues in eliciting maladaptive fear and anxiety responses in psychiatric disorders are likely to be beneficial. The most efficient way to reduce conditioned responses is through the process of extinction, which usually involves repeated exposures to the conditioned stimulus in the absence of the adverse event it once predicted [1], [2].
Research on the role of glutamate and its ionotropic and metabotropic (mGluR) receptors in extinction have led to the development of pharmacotherapies which enhance the efficacy of extinction-based protocols in clinical populations [2]. For example, augmentation of exposure therapy with d-cycloserine, a ionotropic N-methyl-d-aspartate (NMDA) receptor agonist, was shown to improve some anxiety symptoms in SAD [3], [4], PTSD [5], [6], panic disorder [7], and acrophobia [8]. Studies on the contribution of mGluRs to fear extinction have only appeared recently, and knowledge at this time is still limited. Preclinical research suggested that mGluRs may represent promising candidates for pharmacologically improving the outcome of exposure-based therapy. As such, negative allosteric modulation of mGluR5 with 2-methyl-6-(phenylethynyl)-pyridine (MPEP) demonstrated effects against acquisition and retention of conditioned fear [9], [10], [11], [12]. Similarly, allosteric activation of the mGluR7 subtype with N,N’-dibenzyhydryl-ethane-1,2-diamine dihydrochloride (AMN082) blocked acquisition of conditioned fear, but also facilitated extinction of conditioned aversion and fear in two amygdala-dependent paradigms (i.e. conditioned taste aversion and fear-potentiated startle) [13], [14]. However, it is unclear, whether pharmacological modulation of mGluR5 and mGluR7 might also alter coping with, and recovery from, a traumatic social experience. Only a few studies investigated the effects of MPEP on social behaviors and most of these reported that MPEP has the potential to normalize deficits in social interaction. As such, MPEP decreased inter-male aggression and increased social investigation in highly aggressive OF1 mice [15]. It also increased social investigation in Balb/c mice [16], and mice lacking the excitatory synaptic signaling scaffold IRSp53 [17], which were shown to have deficits in social interaction and communication. However, MPEP did not improve social interaction deficits in autistic-like BTBR mice [18] and even decreased social investigation in Swiss Webster mice, which show normal social interaction [16]. So far, only one study investigated the effects of AMN082 on social behavior. In more detail, Navarro et al. [19] have shown that AMN082 decreased inter-male aggression without affecting social investigation in highly aggressive OF1 mice.
In the present study, we aimed to investigate whether pharmacological modulation of mGluR5 and mGluR7 affects acquisition and extinction of conditioned social fear in CD1 mice, which otherwise show normal social interaction [20], [21], [22]. In order to induce social fear, we used the social fear conditioning (SFC) paradigm, which was established to mimic the major behavioral symptoms of SAD, i.e. reduced social investigation and avoidance of con-specifics, as indicative of social fear [23], [24]. In this model, social fear is induced by administration of mild electric foot shocks during the investigation of a con-specific. Importantly, treatment of socially fear-conditioned (SFC+) mice with medication used for SAD patients, such as diazepam and paroxetine, reversed social fear, providing predictive validity to the SFC model [23]. Repeated exposure of the SFC+ mice to unknown con-specifics leads to a gradual decline in the fear response, a process termed social fear extinction. MPEP or AMN082 were administered either prior to SFC (also referred to as acquisition) or social fear extinction in order to determine whether the drugs affected acquisition or extinction of social fear.
Section snippets
Animals
Male CD1 mice (Charles River, Sulzfeld, Germany, 30–35 g) were individually housed for 1 week and transferred to observation cages (30 × 23 × 36 cm) 3 days before experiments started. Age- and weight-matched male CD1 mice were used as social stimuli. Mice were kept under standard laboratory conditions (12:12 light/dark cycle, lights on at 06:00 h, 22 °C, 60% humidity, food and water ad libitum). Experiments were performed during the light phase, between 08:00 and 12:00, in accordance with the Guide for
Effects of MPEP and AMN082 administration prior to SFC on social fear
To investigate whether MPEP and AMN082 influence acquisition of social fear, mice (n = 6/group) were injected i.p. with either vehicle (Veh; 10 ml/kg 0.5% methylcellulose), MPEP, or AMN082 30 min before SFC (Fig. 1A).
Mice showed similar investigation of the non-social stimuli during SFC (F(5,30) = 0.60; p = 0.70), reflecting similar pre-conditioning non-social anxiety. All SFC+ mice received a similar number of foot shocks during SFC (F(2,15) = 0.65; p = 0.54), reflecting similar distress. During social
Discussion
The present findings demonstrate, for the first time, that pharmacological modulation of mGluR5 and mGluR7 affects the extinction of conditioned social fear in a time-point-dependent manner. In more detail, we could show that when administered systemically before SFC neither MPEP nor AMN082 affected acquisition and extinction of social fear. In contrast, when administered before social fear extinction, both MPEP and AMN082 impaired social fear extinction and extinction recall. These findings
Acknowledgement
I.Z. received financial support from the Bayerische Forschungsstiftung.
References (36)
- et al.
A randomized controlled trial of d-cycloserine enhancement of exposure therapy for social anxiety disorder
Biol. Psychiatry
(2008) - et al.
A randomized placebo-controlled trial of d-cycloserine to enhance exposure therapy for posttraumatic stress disorder
Biol. Psychiatry
(2012) - et al.
Efficacy of dcycloserine for enhancing response to cognitive-behavior therapy for panic disorder
Biol. Psychiatry
(2010) - et al.
The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats
Neuropharmacology
(2001) - et al.
Blockade of amygdala metabotropic glutamate receptor subtype 1 impairs fear extinction
Biochem. Biophys. Res. Commun.
(2007) - et al.
Antiaggressive effects of MPEP, a selective antagonist of mGlu5 receptors, in agonistic interactions between male mice
Eur. J. Pharmacol.
(2006) - et al.
Complex effects of mGluR5 antagonism on sociability and stereotypic behaviors in mice: possible implications for the pharmacotherapy of autism spectrum disorders
Brain Res. Bull.
(2011) - et al.
Neuropeptide S reduces fear and avoidance of con-specifics induced by social fear conditioning and social defeat, respectively
Neuropharmacology
(2016) - et al.
Maternal separation facilitates extinction of social fear in adult male mice
Behav. Brain Res.
(2016) - et al.
Pharmacological interference with metabotropic glutamate receptor subtype 7 but not subtype 5 differentially affects within- and between-session extinction of Pavlovian conditioned fear
Neuropharmacology
(2012)
Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist
Biol. Psychiatry
The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine
Biol. Psychiatry
Effects of acute and subchronic treatments with fluoxetine and desipramine on the memory of fear in moderate and high-intensity contextual conditioning
Eur. J. Pharmacol.
Applying learning principles to the treatment of post-trauma reactions
Ann. N. Y. Acad. Sci.
Glutamate receptors in extinction and extinction-based therapies for psychiatric illness
Neuropsychopharmacology
Sudden gains during therapy of social phobia
J. Consult. Clin. Psychol.
Pilot-controlled trial of d-cycloserine for the treatment of post-traumatic stress disorder
Int. J. Neuropsychopharmacol.
Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear
Arch. Gen. Psychiatry
Cited by (10)
The metabotropic glutamate receptor 5 as a biomarker for psychiatric disorders
2023, International Review of NeurobiologyCitation Excerpt :Although ketamine has many effects in addition to the recently implicated mGlu5 downregulation that likely contribute to its efficacy. Alternatively, MPEP has also been shown to prevent the extinction of contextual fear memory in mice (Sethna & Wang, 2016; Slattery, Neumann, Flor, & Zoicas, 2017) and rats (Fontanez-Nuin et al., 2011; Shallcross et al., 2021). Another study found that fear extinction was completely abolished in mGlu5 KO mice (Xu et al., 2009), suggesting that mGlu5 is required for adaptive learning in the context of fear extinction.
How do stupendous cannabinoids modulate memory processing via affecting neurotransmitter systems?
2021, Neuroscience and Biobehavioral ReviewsCitation Excerpt :Further, mice lacking mGluR4 receptor show accelerated spatial learning performance (Gerlai et al., 1998). Administration of MPEP (the mGluR5 antagonist) and AMN082 (the mGluR7 agonist) impairs social fear extinction and extinction recall (Slattery et al., 2017). The role of mGluR2 receptors has been investigated in improving working memory networks (Jin et al., 2018).
Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies
2018, Biological PsychiatryCitation Excerpt :Ketamine has many effects in addition to the recently implicated mGluR5 downregulation that likely contribute to its efficacy.) Alternatively, 2-methyl-6-(phenylethynyl)-pyridine has also been shown to prevent the extinction of contextual fear memory in mice (105,106) and rats (107). Another study found that fear extinction was completely abolished in mGluR5 knockout mice (108), suggesting that mGluR5 is required for adaptive learning in the context of fear extinction.
Social Fear Affects Limbic System Neuronal Activity and Gene Expression
2022, International Journal of Molecular SciencesDifferences in mGluR5 Availability Depending on the Level of Social Avoidance in Drug-Naïve Young Patients with Major Depressive Disorder
2022, Neuropsychiatric Disease and TreatmentNeuropeptide y as alternative pharmacotherapy for antidepressant-resistant social fear
2020, International Journal of Molecular Sciences